Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Donated chemical probes for open science.

Autor: Müller S; Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Frankfurt am Main, Germany., Ackloo S; Structural Genomics Consortium, University of Toronto, Toronto, Canada., Arrowsmith CH; Department of Medical Biophysics, University of Toronto, Toronto, Canada., Bauser M; Drug Discovery Pharmaceuticals, Bayer AG, Berlin, Germany., Baryza JL; Vertex Pharmaceuticals, Boston, United States., Blagg J; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, United Kingdom., Böttcher J; Discovery Research, Boehringer Ingelheim, Vienna, Austria., Bountra C; Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Brown PJ; Structural Genomics Consortium, University of Toronto, Toronto, Canada., Bunnage ME; Vertex Pharmaceuticals, Boston, United States., Carter AJ; Discovery Research, Boehringer Ingelheim, Ingelheim am Rhein, Germany., Damerell D; Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Dötsch V; Institute of Biophysical Chemistry, Goethe-University, Frankfurt am Main, Germany.; Center for Biomolecular Magnetic Resonance, Goethe University, Frankfurt am Main, Germany., Drewry DH; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, United States., Edwards AM; Structural Genomics Consortium, University of Toronto, Toronto, Canada., Edwards J; Janssen Pharmaceutical Research and Development LLC, Spring House, United States., Elkins JM; Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Fischer C; Merck & Co., Inc., Boston, United States., Frye SV; Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, United States., Gollner A; Discovery Research, Boehringer Ingelheim, Biberach an der Riss, Germany., Grimshaw CE; Ched Grimshaw Consulting, LLC, Poway, United States., IJzerman A; Division of Medicinal Chemistry, Leiden University, Leiden, Netherlands., Hanke T; Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Frankfurt am Main, Germany., Hartung IV; Drug Discovery Pharmaceuticals, Bayer AG, Berlin, Germany., Hitchcock S; Takeda California Inc., San Diego, United States., Howe T; J&J Innovation Centre, London, United Kingdom., Hughes TV; J&J Innovation Centre, London, United Kingdom., Laufer S; Department of Pharmaceutical Chemistry, Eberhard Karls Universität Tübingen, Tübingen, Germany., Li VM; Drug Discovery Pharmaceuticals, Bayer AG, Wuppertal, Germany., Liras S; Worldwide Medicinal Chemistry, Pfizer, Cambridge, United States., Marsden BD; Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.; Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom., Matsui H; Takeda Pharmaceutical Company Ltd, Fujisawa, Japan., Mathias J; Worldwide Medicinal Chemistry, Pfizer, Cambridge, United States., O'Hagan RC; Merck & Co., Inc., Boston, United States., Owen DR; Worldwide Medicinal Chemistry, Pfizer, Cambridge, United States., Pande V; Discovery Sciences, Janssen-Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium., Rauh D; Fakultät für Chemie und Chemische Biologie, Technische Universität Dortmund, Dortmund, Germany., Rosenberg SH; AbbVie, North Chicago, United States., Roth BL; The National Institute of Mental Health Psychoactive Active Drug Screening Program, University of North Carolina Chapel Hill School of Medicine, Chapel Hill, United States., Schneider NS; Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Frankfurt am Main, Germany., Scholten C; Drug Discovery Pharmaceuticals, Bayer AG, Berlin, Germany., Singh Saikatendu K; Takeda California Inc., San Diego, United States., Simeonov A; National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, United States., Takizawa M; Takeda Pharmaceutical Company Ltd., Fujisawa, Japan., Tse C; AbbVie, North Chicago, United States., Thompson PR; Department of Biochemistry and Pharmacology, University of Massachusetts Medical School, Worcester, United States., Treiber DK; Eurofins DiscoverX, Sane Diego, United States., Viana AY; Discovery Research, Boehringer Ingelheim, Ingelheim am Rhein, Germany., Wells CI; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, United States., Willson TM; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, United States., Zuercher WJ; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, United States., Knapp S; Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Frankfurt am Main, Germany., Mueller-Fahrnow A; Drug Discovery Pharmaceuticals, Bayer AG, Berlin, Germany.

Publikováno v: ELife [Elife] 2018 Apr 20; Vol. 7. Date of Electronic Publication: 2018 Apr 20.